Avibactam Pharmacokinetic/Pharmacodynamic Targets

Avibactam is a novel non-β-lactam β-lactamase inhibitor that has been approved in the United States and Europe for use in combination with ceftazidime. Combinations of avibactam with aztreonam or ceftaroline fosamil have also been clinically evaluated. Until recently, there has been very little prec...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Nichols, Wright W., Newell, Paul, Critchley, Ian A., Riccobene, Todd, Das, Shampa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2018
Konular:
Minireview
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5971577/
https://ncbi.nlm.nih.gov/pubmed/29610208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02446-17
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller